Vitamin K2 Market: Why the U.S. Growth Rate Matters More Than Its Current Size
A decade ago, most people had never heard of vitamin K2. Today it's a standard ingredient on bone-health and heart-health supplement labels, sold alongside calcium and vitamin D as if it always belonged there. That shift — from nutritional afterthought to mainstream supplement staple — didn't happen by accident, and tracing how it happened explains more about this market's future than the growth percentage alone. The Market Today The global vitamin K2 market was valued at USD 320.0 million in 2025 and is projected to reach USD 1,038.5 million by 2033, growing at a CAGR of 16.6% from 2026 to 2033 — a growth rate that puts it well ahead of the broader dietary supplements category, which typically grows in the high single digits. Asia Pacific currently holds the largest regional share, at 36.7% in 2025, while within the product itself, MK-4 (menaquinone-4) dominates with an 88.5% revenue share. By dosage form, capsules and tablets lead at 41.8%, and synthetic sources ...